title: Ustekinumab-induced drug eruption resembling lymphocytic infiltration (of Jessner-Kanof) and lupus erythematosus tumidus.
authors.affiliation: Department of Clinical Experimental Medicine, Section of Dermatology, A.O.U. Policlinico 'G. Martino', University of Messina, Messina, Italy.
authors.forename: Claudio
authors.initials: C
authors.lastname: Guarneri
authors.affiliation: Department of Human Pathology, A.O.U. Policlinico 'G. Martino', University of Messina, Messina, Italy.
authors.forename: Maria
authors.initials: M
authors.lastname: Lentini
authors.affiliation: Unit of Clinical Pharmacology, Sicilian Regional Centre of Pharmacovigilance, A.O.U. Policlinico 'G. Martino', University of Messina, Messina, Italy.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Polimeni
authors.affiliation: Department of Clinical Experimental Medicine, Section of Dermatology, A.O.U. Policlinico 'G. Martino', University of Messina, Messina, Italy.
authors.forename: Roberta
authors.initials: R
authors.lastname: Giuffrida
authors.affiliation: Department of Clinical Experimental Medicine, Section of Dermatology, A.O.U. Policlinico 'G. Martino', University of Messina, Messina, Italy.
authors.forename: Serafinella P
authors.initials: SP
authors.lastname: Cannavò
mesh_terms: D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D006801:Humans; D008179:Lupus Erythematosus, Discoid / Q000175:diagnosis; D008218:Lymphocytosis / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy; D016896:Treatment Outcome; D000069549:Ustekinumab / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000069549:Ustekinumab